Review



gclc antibody  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Boster Bio gclc antibody
    Gclc Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc antibody/product/Boster Bio
    Average 92 stars, based on 3 article reviews
    gclc antibody - by Bioz Stars, 2026-03
    92/100 stars

    Images



    Similar Products

    96
    Proteintech gclc
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gclc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc/product/Proteintech
    Average 96 stars, based on 1 article reviews
    gclc - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech glutamate cysteine ligase catalytic subunit gclc
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Glutamate Cysteine Ligase Catalytic Subunit Gclc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutamate cysteine ligase catalytic subunit gclc/product/Proteintech
    Average 96 stars, based on 1 article reviews
    glutamate cysteine ligase catalytic subunit gclc - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech glutamate cysteine ligase catalytic subunit
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Glutamate Cysteine Ligase Catalytic Subunit, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/glutamate cysteine ligase catalytic subunit/product/Proteintech
    Average 96 stars, based on 1 article reviews
    glutamate cysteine ligase catalytic subunit - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech 12601 1 ap
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    12601 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/12601 1 ap/product/Proteintech
    Average 96 stars, based on 1 article reviews
    12601 1 ap - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    Proteintech gclc cat cfp marco were purchased
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gclc Cat Cfp Marco Were Purchased, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc cat cfp marco were purchased/product/Proteintech
    Average 96 stars, based on 1 article reviews
    gclc cat cfp marco were purchased - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    92
    Boster Bio gclc antibody
    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, <t>HO-1,</t> <t>NQO1,</t> and <t>GCLC</t> antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group
    Gclc Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gclc antibody/product/Boster Bio
    Average 92 stars, based on 1 article reviews
    gclc antibody - by Bioz Stars, 2026-03
    92/100 stars
      Buy from Supplier

    Image Search Results


    TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group

    Journal: Chinese Medicine

    Article Title: Thonningianin A derived from Penthorum chinense Pursh alleviates cerebral ischemia/reperfusion-mediated apoptosis and pyroptosis through the activation of PINK1/Parkin-dependent mitophagy

    doi: 10.1186/s13020-025-01247-2

    Figure Lengend Snippet: TA improved mitochondrial oxidative damage. A The death rate of HT22 cells was measured by Hoechst/PI staining in HT22 cells after 24 h of OGD/R induction and TA treatment. Magnification: 10 × , scale bar: 200 μm. B Representative images showing ROS release (DHE staining) and viable cells (Hoechst staining) in HT22 cells following OGD/R with or without TA treatment, × 10, scale bar: 200 μm. Bar chart indicates the rate of PI/Hoechst. *** p < 0.001 versus OGD/R alone group, n = 3. C Representative JC-1 staining images depict MMP in HT22 cells following OGD/R with or without TA treatment. Red fluorescence indicates JC-1 aggregates, while green fluorescence indicates the monomeric form. Magnification: 10 × , scale bar: 200 μm. D HT22 cells underwent OGD/R and TA treatment, followed by incubation with Hoechst reagent and Mito-Tracker ™ Red CMXRos to stain nuclei and mitochondria. Images were acquired using a confocal laser scanning microscope. Magnification: 64 ×, scale bar: 5 μm. E The bar chart indicates the DHE/Hoechst rate of HT22 cells. * p <0.05 and *** p < 0.001 versus OGD/R alone group, n = 3. F After 24 h of OGD/R induction and TA treatment, HT22 cell viability was measured by MTT assay, the result is as shown in the bar chart. * p < 0.05, ** p < 0.01 and *** p < 0.001 , and versus OGD/R group, n = 6. G The bar chart indicates the DHE/Hoechst rate of HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. H The bar chart illustrates the ratio of JC-1 aggregates to monomers in HT22 cells. *** p < 0.001 versus OGD/R alone group, n = 3. I The bar chart indicates mitochondrial length of HT22 cells in different group. *** p < 0.001 versus OGD/R alone group, n = 3. J Detection of nuclear Nrf2, HO-1, NQO1, and GCLC antioxidant protein expression by Western blotting. K HT22 cells subjected to OGD/R with or without TA, or TA + ML385 (an Nrf2 inhibitor), Western blotting was used to detect Nrf2 protein expression levels. L – O The bar chart indicates the ratios of nuclear Nrf2/LaminB, HO-1/β-actin, NQO1/GAPDH, GCLC/GAPDH. * p < 0.05, ** p < 0.01 and *** p < 0.001 versus OGD/R alone group. P The bar chart demonstrates that TA treatment enhanced OGD/R-induced nuclear Nrf2 expression, an effect reversed by the Nrf2 inhibitor ML385. *** p < 0.001 versus OGD/R group or OGD/R + TA group

    Article Snippet: Antibodies against GSDMD (20770-1-Ap), Caspase-3 (25158-1-Ap), Caspase-9 (10380-1-Ap), NQO1 (11451-1-Ap), GCLC (12601-1-Ap), LC3 (14600-1-Ap), PINK1 (23274-1-Ap), Parkin (14060-1-Ap), Antibody Caspase-1 (22,915-1-ap), GAPDH (6004-1-Ig), β-actin (66009-1-Ig), CoraLite ® Plus 488 goat anti-rabbit IgG (RGAR002), CoraLite ® Plus 594-Goat Anti-Mouse IgG (RGAR002), were purchased from Proteintech Group, Inc (Wuhan, China).

    Techniques: Staining, Fluorescence, Incubation, Laser-Scanning Microscopy, MTT Assay, Expressing, Western Blot